This defect derives, at least in part, from aberrant increase in the levels of Erα, an alternative AhR partner, which is upregulated in AIH Tregs; and from high expression of HIF-1α, an AhR inhibitor, which is upregulated in AIH Th17-cells. The gene discussed is HIF1A; the disease is autoimmune hepatitis.